Optomed Oyj: Business Overview, Financials & Competitive Analysis
Optomed Oyj scores 7/10 on the AskCyborg Cyborg Score (Solid). Optomed is a specialized medical technology innovator well-positioned in the high-growth diabetic retinopathy screening market with proven technology and expanding global distribution. Optomed operates in a growing healthcare sector with strong AI-integrated technology, demonstrated by recent robust growth in its Devices segment and global expansion across 60+ countries. The company's.
What is Optomed Oyj's industry? Optomed Oyj (optomed.com) operates in Medical Technology / Ophthalmic Devices. AskCyborg classifies Optomed Oyj under Medical Technology / Ophthalmic Devices in its company registry.
Optomed is a Finnish medical technology company and a leading manufacturer of handheld fundus cameras and screening software that combines these devices with AI to transform the diagnostic process of blinding eye dise...
Cyborg Score thesis
Optomed is a specialized medical technology innovator well-positioned in the high-growth diabetic retinopathy screening market...
Read the full analyst-debate transcript →Get the Latest Optomed Oyj Report
Up-to-date AI-powered research, analyst debate audio & saved-company playlists
Get Current Report FreeOptomed Oyj Overview
Pro stress-test →Optomed is a Finnish medical technology company and a leading manufacturer of handheld fundus cameras and screening software that combines these devices with AI to transform the diagnostic process of blinding eye diseases, such as diabetic retinopathy. The company has offices in Finland, the US and China and sells products via various sales channels in over 60 countries globally.
Strategic Profile
Pro stress-test →Optomed operates in two business segments: Devices and Software. The company has an extensive portfolio of over 50 international patents protecting its technology and has medical approvals in all key markets, including CE (Europe), FDA (USA), and CFDA (China). The Devices segment achieved 47.0% currency-adjusted growth in Q3 2025, with the US market performing very well.
Competitive Landscape
Pro stress-test →Revenio Group, a corporate-backed company based in Vantaa, Finland, is one of Optomed's main competitors. Optomed differentiates through its integrated hardware-software-AI approach targeting ophthalmology and primary healthcare settings, with a focus on handheld devices for accessibility and diabetic retinopathy screening.
Industry Context
Optomed Oyj operates in Medical Technology / Ophthalmic Devices.
Key facts
Founded: 2004 · Headquarters: Oulu, Finland · Employees: 100